A 2026 case-control imaging study found that 23 women with premenstrual dysphoric disorder had higher left DTI-ALPS glymphatic index than 27 healthy controls (p = 0.024), plus wider hypothalamus connectivity across emotion and subcortical networks.1 The result adds a brain-fluid-clearance and stress-network layer to PMDD biology, but the evidence is still small-sample imaging rather than …
A 2026 PLOS One machine-learning study reported 95.0% accuracy for a hybrid FT-Transformer plus long short-term memory (LSTM) model predicting student mental-health risk. The technical result is strong inside the dataset, but the clinical claim is still limited because the labels came from repository data rather than prospective clinical diagnosis.1 Research Highlights 95.0% accuracy was …
A Wuhan cohort of 2,210 pregnant women found that mid-pregnancy sleep disturbance was common enough to screen for and associated with several birth-outcome signals. Depressive symptoms, pre-pregnancy alcohol use, and moderate-to-severe vomiting raised sleep-disturbance odds, while higher dietary variety was protective.1 Research Highlights 18.14% had sleep disturbance: Pittsburgh Sleep Quality Index (PSQI) scores greater than …
A 2026 analysis followed 161 people with cancer for 9 months to evaluate whether 2 forms of online mindfulness-based cognitive therapy reduced psychological distress: therapist-led group-blended care and individual self-guided modules. Psychological distress improved significantly in both formats, but fewer participants dropped out when the program included therapist-led group sessions. Research Highlights Distress improved through …
A 2026 preclinical study found that 25C-NBF, a selective 5-HT2A psychedelic phenethylamine, increased plasticity-related markers and produced rapid antidepressant-like effects in male rodents, while showing no detected reward or reinforcement signal in the models tested. Research Highlights 25C-NBF was preclinical: Nadal-Gratacos et al. tested cells, male mice, and male rats, not patients with depression.1 5-HT2A …
A 2026 review in Purinergic Signalling argues that P2X7 receptors are one of the clearest molecular bridges between stress, ATP danger signaling, microglial inflammation, NLRP3 inflammasome activation, reduced BDNF, and new antidepressant drug targets.1 Research Highlights P2X7 is the lead receptor: Mattova et al. reviewed 7 ATP-gated P2X receptor subunits, with P2X7 carrying the strongest …
A 2026 systematic review found that microglia-related immune signals do not line up cleanly with psychiatric diagnosis labels: major depression showed frontolimbic TSPO-PET increases, while schizophrenia showed elevated kynurenic acid in cerebrospinal fluid.1 The strongest interpretation is that immune-brain markers may sort subgroups better than DSM categories do. Research Highlights Depression had the clearest TSPO-PET …